Sign up to save your podcasts
Or
Share The For-Profit President?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The For-Profit President?
Rangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss the recent controversy over Mylan's (MYL) EpiPen, the "dinner with Trump" PAC scandal, and Trump's for profit campaign.
View all episodes
By Rangeley Capital PodcastRangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss the recent controversy over Mylan's (MYL) EpiPen, the "dinner with Trump" PAC scandal, and Trump's for profit campaign.